by reuters-news
Posted on: November 12, 2012 by reuters-newsNo Comments »
EarlySense, an Israeli-U.S. developer of patient monitoring systems, has raised $15 million in a financing round led by Israeli fund Pitango Venture Capital. Existing investors that participated include JK&B, ProSeed VC Fund, Docor International Management and Bridge Investment Fund.
The surging popularity of bitcoin has some brand-name venture capitalists investing real money in the controversial virtual currency. Just since
Author : laragon
TPG has had much luck tapping the IPO market during the past 12 months. The PE firm’s most recent success
Author : lbeltran
This week marks the one-year anniversary of Facebook’s public offering, one of the most highly anticipated market events in Wall
Author : connieloizos
Blackstone Group LP is planning to create a hedge fund which will consist of the boldest trades from the third-party
Author : reuters-news
Long before taking the helm as CEO of Twitter, Dick Costolo was an aspiring comic at Chicago’s famed The Second
Author : joanna
Welcome! Join the peHUB community to make connections, share your opinion, and follow your favorite authors. It's quick and easy.
Click here to get started!
Kirk Falconer wrote a new post, Welcome to peHUB Canada! 31 minutes ago
Kirk Falconer wrote a new post, Relay Ventures’ Big Score 1 hour, 4 minutes ago
Luisa Beltran wrote a new post, Bessemer Venture Leads $45 Mln Round for Adaptive Planning 1 hour, 35 minutes ago
Adaptive Planning said Tuesday it secured $45 million in venture funding led by Bessemer Venture Partners. Existing investors ONSET Ventures, Norwest Venture Partners (NVP), RBC Venture Partners, Cardinal Venture […]
Luisa Beltran wrote a new post, KPS Inks Buys of Wausau Specialty Paper, Thilmany 2 hours, 5 minutes ago
KPS said Monday it has agreed to buy the specialty paper business of Wausau Paper Corp. The PE firm is also buying the specialty paper business of Packaging Dynamics Corp., which is known as Thilmany. The […]
Luisa Beltran wrote a new post, 3i Sells Xelia Pharma to Novo Group 2 hours, 16 minutes ago
The Novo Group has acquired Xellia Pharmaceuticals for about $700 million. The sellers are 3i and other Xelia shareholders. Xelia, of Oslo, Norway, is a specialty pharmaceutical company focused on anti-infective […]
